ARTICLE | Management Tracks
Innovent hires Gracell vet Samuel Zhang as CBO
Plus: CEO changes at Lexicon, Avacta and Sphere Fluidics, and updates from Generate, Charm, ViaNautis and more
April 30, 2024 10:55 PM UTC
Innovent Biologics Inc. (HKEX:1801) hired Samuel Zhang as global CBO. Zhang was CBO of Gracell Biotechnologies Inc., where he played a role in that company’s acquisition by AstraZeneca plc (LSE:AZN; NASDAQ:AZN). Before Gracell, he was CBO at NeoImmuneTech Inc. (KOSDAQ:950220).
Lonnel Coats will retire as CEO and board member of Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) on July 7. The cardiovascular and metabolic disorders company has begun the search for a successor...